Reversal of T cell exhaustion enables cancer vaccine efficacy in BRCA1-deficient ovarian cancer.

Beziaud L, Minasyan A, Chiang CL, Soukarieh RM, Coppi MM, Rovelli R, Thevenet J, Tissot S, Dangaj-Laniti D, Kandalaft LE

Open source

DOI
10.1016/j.isci.2026.116587
Published
2026 Jul 17
Container
iScience
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.isci.2026.116587,
  title = {Reversal of T cell exhaustion enables cancer vaccine efficacy in BRCA1-deficient ovarian cancer.},
  author = {Beziaud L and Minasyan A and Chiang CL and Soukarieh RM and Coppi MM and Rovelli R and Thevenet J and Tissot S and Dangaj-Laniti D and Kandalaft LE},
  year = {2026},
  journal = {iScience},
  doi = {10.1016/j.isci.2026.116587},
  url = {https://doi.org/10.1016/j.isci.2026.116587}
}

RIS

TY  - JOUR
TI  - Reversal of T cell exhaustion enables cancer vaccine efficacy in BRCA1-deficient ovarian cancer.
AU  - Beziaud L
AU  - Minasyan A
AU  - Chiang CL
AU  - Soukarieh RM
AU  - Coppi MM
AU  - Rovelli R
AU  - Thevenet J
AU  - Tissot S
AU  - Dangaj-Laniti D
AU  - Kandalaft LE
PY  - 2026
JO  - iScience
DO  - 10.1016/j.isci.2026.116587
UR  - https://doi.org/10.1016/j.isci.2026.116587
ER  - 

APA

L, B., A, M., CL, C., RM, S., MM, C., R, R., J, T., S, T., D, D., & LE, K. (2026). Reversal of T cell exhaustion enables cancer vaccine efficacy in BRCA1-deficient ovarian cancer.. iScience. https://doi.org/10.1016/j.isci.2026.116587

Source records